|
1
|
Liang R, Bai QX, Zhang YQ, et al: Reduced
tumor lysis syndrome with low dose chemotherapy for hyperleukocytic
acute leukemia prior to induction therapy. Asian Pac J Cancer Prev.
12:1807–1811. 2011.PubMed/NCBI
|
|
2
|
Krivtsov AV, Figueroa ME, Sinha AU, et al:
Cell of origin determines clinically relevant subtypes of
MLL-rearranged AML. Leukemia. 27:852–860. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Barjesteh van Waalwijk van
Doorn-Khosrovani S, Erpelinck C, van Putten WL, et al: High EVI1
expression predicts poor survival in acute myeloid leukemia: a
study of 319 de novo AML patients. Blood. 101:837–845.
2003.PubMed/NCBI
|
|
4
|
Konantz M, André MC, Ebinger M, et al:
EVI-1 modulates leukemogenic potential and apoptosis sensitivity in
human acute lymphoblastic leukemia. Leukemia. 27:56–65. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
5
|
De Weer A, Poppe B, Cauwelier B, et al:
Screening for EVI1: ectopic expression absent in T-cell acute
lymphoblastic leukemia patients and cell lines. Cancer Genet
Cytogenet. 171:79–80. 2006.PubMed/NCBI
|
|
6
|
Valk PJ, Verhaak RG, Beijen MA, et al:
Prognostically useful gene-expression profiles in acute myeloid
leukemia. N Engl J Med. 350:1617–1628. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Yuasa H, Oike Y, Iwama A, et al: Oncogenic
transcription factor Evi1 regulates hematopoietic stem cell
proliferation through GATA-2 expression. EMBO J. 24:1976–1987.
2005. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Goyama S, Yamamoto G, Shimabe M, et al:
Evi-1 is a critical regulator for hematopoietic stem cells and
transformed leukemic cells. Cell Stem Cell. 3:207–220. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Hoyt PR, Bartholomew C, Davis AJ, et al:
The Evi1 proto-oncogene is required at midgestation for neural,
heart, and paraxial mesenchyme development. Mech Dev. 65:55–70.
1997. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Brooks DJ, Woodward S, Thompson FH, et al:
Expression of the zinc finger gene EVI-1 in ovarian and other
cancers. Br J Cancer. 74:1518–1525. 1996. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Morishita K, Parganas E, Douglass EC and
Ihle JN: Unique expression of the human Evi-1 gene in an
endometrial carcinoma cell line: sequence of cDNAs and structure of
alternatively spliced transcripts. Oncogene. 5:963–971.
1990.PubMed/NCBI
|
|
12
|
Fears S, Mathieu C, Zeleznik-Le N, Huang
S, Rowley JD and Nucifora G: Intergenic splicing of MDS1 and EVI1
occurs in normal tissues as well as in myeloid leukemia and
produces a new member of the PR domain family. Proc Natl Acad Sci
USA. 93:1642–1647. 1996. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Jiang GL and Huang S: The yin-yang of
PR-domain family genes in tumorigenesis. Histol Histopathol.
15:109–117. 2000.PubMed/NCBI
|
|
14
|
Nitta E, Izutsu K, Yamaguchi Y, et al:
Oligomerization of Evi-1 regulated by the PR domain contributes to
recruitment of corepressor CtBP. Oncogene. 24:6165–6173. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Shackelford D, Kenific C, Blusztajn A,
Waxman S and Ren R: Targeted degradation of the AML1/MDS1/EVI1
oncoprotein by arsenic trioxide. Cancer Res. 66:11360–11369. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Dhanasekaran DN and Reddy EP: JNK
signaling in apoptosis. Oncogene. 27:6245–6251. 2008. View Article : Google Scholar
|
|
17
|
Kurokawa M, Mitani K, Yamagata T, et al:
The evi-1 oncoprotein inhibits c-Jun N-terminal kinase and prevents
stress-induced cell death. EMBO J. 19:2958–2968. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Garrison SP, Phillips DC, Jeffers JR, et
al: Genetically defining the mechanism of Puma- and Bim-induced
apoptosis. Cell Death Differ. 19:642–649. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Coiras M, López-Huertas MR, Mateos E and
Alcami J: Caspase-3-mediated cleavage of p65/RelA results in a
carboxy-terminal fragment that inhibits IkappaBalpha and enhances
HIV-1 replication in human T lymphocytes. Retrovirology. 5:1092008.
View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Sun C, Guo XX, Zhu D, et al: Apoptosis is
induced in cancer cells via the mitochondrial pathway by the novel
xylocydine-derived compound JRS-15. Int J Mol Sci. 14:850–870.
2013. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Yang Y, Duan W, Liang Z, et al: Curcumin
attenuates endothelial cell oxidative stress injury through Notch
signaling inhibition. Cell Signal. 25:615–629. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Lin WJ, Shen LJ, Chen FY, Zhong M, Sun RL
and Zhong JH: The establishment of AML1-EVI1 transgenic zebrafish
model and regulation of hematopoietic transcription factors.
Journal of Internal Medicine Concepts & Practice. 3:192–196.
2013.(In Chinese).
|
